Skip to main content
Clinical Trials/NCT01182051
NCT01182051
Completed
N/A

A Pilot Study of Family-based Cognitive-behavioral Therapy for Treating Chronic Pediatric Headache/Migraine and Comorbid Anxiety

Johns Hopkins University1 site in 1 country15 target enrollmentMarch 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pediatric
Sponsor
Johns Hopkins University
Enrollment
15
Locations
1
Primary Endpoint
Daily Headache and Anxiety Diary
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The primary aim of this proposal is to refine the intervention under investigation (i.e., family-based CBT) and evaluate the feasibility and acceptability of the intervention and methods (e.g., recruitment, assessments).

The secondary aim of this proposal is to compare the relative efficacy of an 8 session family-based cognitive-behavioral therapy (CBT) to Relaxation Training (RT) for reducing anxiety and chronic headaches in youth (N = 30) ages 7-17 years. It is hypothesized that CBT will result in greater reductions in both anxiety and headache frequency and severity compared to RT.

Detailed Description

Chronic daily headache in children, as well as periodic migraine, is a prevalent, persistent, and debilitating pain condition affecting nearly 1 in 10 children. Emerging evidence suggests that affected youth also experience excessive and impairing symptoms of anxiety which may play a role in the etiology and/or maintenance of headache pain. Current behavioral treatments are effective in reducing headache frequency and intensity, however, many youth remain symptomatic and the exacerbating role of anxiety has largely been ignored. Moreover, current psychosocial treatments fail to incorporate parents in the therapeutic process. The current proposal is a pilot study designed to address the shortcomings of current behavioral treatments by evaluating the initial efficacy of a family-based cognitive-behavioral therapy (CBT) for youth who present with chronic tension headaches and migraines, and excessive anxiety. Rigorous scientific methods will be employed, including a randomized design, multiple informants and measures to assess key constructs, independent evaluators (IEs) to assess outcomes, and intensive training for therapists and IEs to assure a high quality of implementation. Using a pre-post experimental design, 30 youth with chronic tension headaches and/or migraines and anxiety will be randomly assigned to receive 8 weeks of family-based CBT or relaxation training (RT). IEs will complete assessments of child symptoms and functioning at pre and post-treatment and at one month follow-up. Youth in the family-based CBT condition are expected to evince greater reductions in both headache and anxiety frequency, severity, and duration. Results from this study will be used to make empirically informed modifications to the CBT treatment manual in order to facilitate replication and dissemination of the interventions to clinicians and researchers.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
June 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Golda S. Ginsburg, Ph.D.

Professor

Johns Hopkins University

Eligibility Criteria

Inclusion Criteria

  • To determine eligibility, youth will complete an evaluation consisting of clinical interviews, self-, and parent-report measures.
  • To be included in the study, all children must:
  • have a current diagnosis of chronic daily headache, tension-type headache, and/or migraine headache
  • obtain a total score on the Screen for Child Anxiety Related Disorders (SCARED) in the clinical range (i.e., \> 20)
  • be between 7 and 17 years old
  • have a parent/guardian who gives consent and agrees to participate
  • be English speaking
  • not currently participating in other psychosocial treatments specifically directed at reducing head pain or anxiety.
  • For youth receiving prophylactic medication, it is preferable that they remain on a stable dose and agree to avoid medication changes while enrolled in the study. Thus, all participants will be permitted to continue with their prescribed medical/neurological treatment, however the use of medications (both prophylactic and over-the-counter analgesics) will be closely monitored.

Exclusion Criteria

  • Youth will be excluded from the study if they have a medical or psychiatric condition contraindicating study treatment or warranting an alternative intervention (e.g., suicidality, depression).

Outcomes

Primary Outcomes

Daily Headache and Anxiety Diary

Time Frame: Daily for three months

Youth and parents will complete a daily headache and anxiety diary to track the frequency and severity of headaches and anxiety symptoms. In addition, the diary will assess medication use, missed school/activities, as well as antecedents and consequences.

Pediatric Anxiety Rating Scale (PARS)

Time Frame: 2 months

The Pediatric Anxiety Rating Scale (PARS) will be completed by an independent evaluator to assess the severity of current (within the past week) anxiety symptoms in youth. The instrument consists of two sections. The first section contains a 50-item anxiety symptoms checklist. The second section assesses the severity and impairment of these symptoms. A total score is computed by summing the severity items. The measure has acceptable internal consistency, reliability, and convergent/divergent validity.

Secondary Outcomes

  • Pediatric Migraine Disability Assessment (PedMIDAS)(3 months)
  • Pediatric Anxiety Rating Scale (PARS)(3 months)

Study Sites (1)

Loading locations...

Similar Trials